Novo Nordisk diabetes pill delivers in late-stage trial; Gilead partners with Sangamo on engineered cell therapies; Study finds antidepressants work, though with varying results.
Five things for pharma marketers to know: Wednesday, May 25, 2016
Antidepressants are often used to treat conditions other than depression; the FDA delays decision on Duchenne drug; Lilly and Pfizer develop new painkiller
Five things for pharma marketers to know: Thursday, September 17, 2015
New analysis says Paxil is not safe or effective for teens; some FDA reviewers voted against Addyi approval over side effects; HHS partners with AstraZeneca on antibiotic development
Loading...
MM+M Transform: The Patient, Provider and Payer Engagement Matrix